Skip to content

Dalia Sriwi, M.B.B.S.

NPI 1740910579ActiveIndividual· Internal Medicine, Rheumatology· Salt Lake City, UT

Internal Medicine, Rheumatology (M.B.B.S.) in Salt Lake City, Utah, licensed in UT and WI, with an NPI issued in June 2022. Part D covered 138 prescriptions written in 2024, 85% of them generic. Amgen Inc. was the largest of 3 companies reporting payments in 2025, $349.42 in all, mostly food and beverage.

Overview

NPI1740910579
StatusActive
Entity typeIndividual
CredentialM.B.B.S.
Sole proprietorNo
NPI issuedJun 14, 2022
Last updated in NPPESMar 11, 2025
Certified by providerMar 7, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (WI)

Part D prescriptions in 2024

Prescriptions (claims)138 · 276 30-day fills
Patients37
Total drug cost$8,239
Generic share85% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$349.42 · 3 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Amgen Inc.$121.831
Ucb, Inc.$115.621
Janssen Scientific Affairs, LLC$111.971

What the 2025 payments were for

  • Food and Beverage$349.42 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other rheumatologists in Salt Lake City

All 28 rheumatologists in Salt Lake City · All rheumatologists in Utah